Why the study?
Does H.261 reduce angiotensin II and mean arterial pressure compared to captopril in anaesthetized baboons?
Does H.261 reduce angiotensin II and mean arterial pressure compared to captopril in anaesthetized baboons?
The novel renin inhibitor H.261 acutely lowers blood pressure and angiotensin II levels in baboons to a similar extent as captopril.
Answers are grounded in this paper and cite their sources.
H.261 supports preclinical testing of renin inhibition; leaves open translation to human hypertension trials.
H.261, a new transition state inhibitor of human renin with an IC50 of 6.9 X 10(-10) M, was given by intravenous infusion to six anaesthetized baboons. The inhibitor was infused first at 0.1 mumol/kg/h for 15 min, then at 1.0 mumol/kg/h for a further 15 min. After a recovery period of 2 h in which the animals received 5% dextrose, they were infused with captopril, 25 mumol/kg/h for 15 min. At both rates of infusion H.261 markedly and significantly reduced the enzymatic action of renin in plasma, the blood concentration of angiotensin I, the plasma concentration of angiotensin II and mean arterial pressure. All changes reverted towards or to control values in the subsequent control period. Captopril also lowered plasma angiotensin II concentration and mean arterial pressure markedly and significantly but, as expected for an inhibitor of the angiotensin I-converting enzyme, plasma active renin concentration and blood angiotensin I concentration increased. The changes of angiotensin II and arterial pressure were similar with captopril and H.261.
No takes yet. Share an insight, caveat, or question.
Szelke et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: